Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
The Lancet Microbe is Scopus-indexed (Q1, CiteScore 24.8), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 2666-5247Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 9 / 361 | 97th | Q1 |
| Microbiology (medical) | 4 / 147 | 97th | Q1 |
| Virology | 3 / 86 | 97th | Q1 |
| Microbiology | 7 / 194 | 96th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q1, CiteScore 24.8.
The Lancet Microbe is Q1 in Infectious Diseases (rank 9 of 361), Q1 in Microbiology (medical) (rank 4 of 147) and Q1 in Virology (rank 3 of 86), by CiteScore 2025. It is ranked in 4 subject areas in all.
The Lancet Microbe is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 24.8, which places it in quartile Q1 at the 97th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 5.192, quartile Q1, with an H-index of 67.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$7,280 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
The Lancet Microbe is published by Elsevier Ltd. Its ISSN is 2666-5247.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
The Lancet Microbe has an h-index of 92 and a 2-year mean of 11.84 citations per paper (OpenAlex). Its Scopus CiteScore is 24.8, quartile Q1. On 2-year citations it ranks #10 of 354 Scopus journals in Infectious Diseases.
The Lancet Microbe published 245 papers in 2025; its busiest recent year was 2024 with 263. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 88 research articles (2026), authors are most often from United Kingdom (14.6%), United States (12.7%) and China (9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.